Skip to content
Politics
Health

Uganda to Start Ebola Vaccine Trials in Two Weeks as Cases Rise

A person photographs an image of the Ebola virus. 

A person photographs an image of the Ebola virus. 

Photographer: David McNew/Getty Images

Uganda plans to start trials for Ebola candidate vaccines in two weeks as it seeks to curb the spread of the disease, with infections confirmed in several districts including the capital, Kampala.

The government will evaluate the efficacy of the vaccines from University of Oxford, Sabin Vaccine Institute and Merck on those who were in contact with infected persons, Minister of Health Jane Ruth Aceng told reporters Wednesday in the capital, Kampala. Initially, around 3,000 people will be inoculated, she said.